Holdings

Avidity Partners Management LP

As of Sep 30, 2026, Avidity Partners Management LP reported 16 positions worth US$427M. Largest: Dianthus Therapeutics, Inc., CG Oncology, Inc. and Oruka Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Dianthus Therapeutics, Inc.1.9MUS$167M−205KSep 30, 2026
CG Oncology, Inc.1.35MUS$95.6M−50,000Sep 30, 2026
Oruka Therapeutics, Inc.785KUS$65.4M+25,000Sep 30, 2026
Jade Biosciences, Inc.2MUS$28.1M+299KSep 30, 2026
Enliven Therapeutics, Inc.550KUS$25.2Mno changeSep 30, 2026
Perspective Therapeutics, Inc.6.07MUS$16.7M−232KSep 30, 2026
Aktis Oncology, Inc.484KUS$9.43Mno changeSep 30, 2026
Immunic, Inc.670KUS$6.23Mno changeSep 30, 2026
Mobia Medical, Inc.325KUS$3.07M−474KSep 30, 2026
Palvella Therapeutics, Inc.20,000US$2.76M−50,000Sep 30, 2026